Galderma presents new scientific dermatology data at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, March 27–31. The company shares 22 abstracts, including late‑breaking data and oral presentations. These sessions span therapeutic dermatology and skin care science. Atopic dermatitis presentations include late-breaking data Galderma presents late‑breaking data on Nemluvio® (nemolizumab) for moderate‑to‑severe atopic dermatitis across different ...